J. Goldman & Co’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$386K Buy
+11,140
New +$299K 0.01% 580
2024
Q3
Sell
-223,955
Closed -$4.52M 522
2024
Q2
$4.52M Buy
+223,955
New +$3.73M 0.13% 181
2023
Q4
Sell
-70,283
Closed -$442K 394
2023
Q3
$442K Buy
+70,283
New +$523K 0.02% 287
2023
Q2
Sell
-62,084
Closed -$616K 426
2023
Q1
$616K Sell
62,084
-1,062,667
-94% -$9.31M 0.02% 253
2022
Q4
$7.21M Buy
1,124,751
+556,824
+98% +$3.17M 0.35% 80
2022
Q3
$3.17M Sell
567,927
-1,037,829
-65% -$6.25M 0.15% 163
2022
Q2
$7.27M Buy
+1,605,756
New +$6.85M 0.35% 76

Other funds holding HIMS

J. Goldman & Co's HIMS Position: Q2 2026 in Review

J. Goldman & Co opened a new position in Hims & Hers Health (HIMS) in Q2 2026: 11,140 shares worth $386K. The stake represents 0.01% of the portfolio and ranks #580 among its holdings. This is a return to the name: J. Goldman & Co previously reported a position in HIMS as recently as Q2 2024.

J. Goldman & Co first reported a position in HIMS in Q2 2022 and has held it in 7 quarters since. The position peaked at $7.27M in Q2 2022. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • J. Goldman & Co held 11,140 shares of Hims & Hers Health worth $386K as of Q2 2026.
  • Hims & Hers Health was a new J. Goldman & Co position in Q2 2026.
  • Hims & Hers Health made up 0.01% of J. Goldman & Co's portfolio in Q2 2026, its #580 holding.
  • J. Goldman & Co first reported a position in Hims & Hers Health in Q2 2022 and has held it in 7 quarters since.
  • J. Goldman & Co's Hims & Hers Health position peaked at $7.27M in Q2 2022.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.